Raymond James & Associates’s Team Health Holdings Inc TMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-37,879
Closed -$1.65M 3485
2016
Q4
$1.65M Sell
37,879
-85,921
-69% -$3.55M ﹤0.01% 1612
2016
Q3
$4.03M Buy
123,800
+4,455
+4% +$164K 0.01% 1062
2016
Q2
$4.85M Sell
119,345
-814
-0.7% -$35.5K 0.02% 869
2016
Q1
$5.02M Buy
120,159
+56,218
+88% +$2.3M 0.02% 819
2015
Q4
$2.81M Sell
63,941
-889
-1% -$47.1K 0.01% 1080
2015
Q3
$3.5M Buy
64,830
+1,960
+3% +$122K 0.01% 924
2015
Q2
$4.11M Buy
62,870
+19,363
+45% +$1.17M 0.02% 908
2015
Q1
$2.55M Sell
43,507
-3,632
-8% -$206K 0.01% 1114
2014
Q4
$2.71M Buy
47,139
+9,743
+26% +$561K 0.01% 995
2014
Q3
$2.17M Buy
37,396
+1,774
+5% +$99K 0.01% 1061
2014
Q2
$1.78M Sell
35,622
-944
-3% -$45.7K 0.01% 1157
2014
Q1
$1.64M Buy
36,566
+5,058
+16% +$228K 0.01% 1149
2013
Q4
$1.44M Buy
31,508
+1,045
+3% +$46.5K 0.01% 1117
2013
Q3
$1.16M Sell
30,463
-27,625
-48% -$1.08M 0.01% 1170
2013
Q2
$2.39M Buy
+58,088
New +$2.24M 0.02% 722

Other funds holding TMH

Raymond James & Associates's TMH Position: Q1 2017 in Review

Raymond James & Associates sold out of Team Health Holdings Inc (TMH) in Q1 2017, closing a stake of 37,879 shares — an estimated $1.65M sold.

Raymond James & Associates first reported a position in TMH in Q2 2013 and held it in 15 quarters. The position peaked at $5.02M in Q1 2016. 9 funds tracked by Wall St. Rank hold TMH as of Q1 2017.

  • Raymond James & Associates reported no remaining Team Health Holdings Inc position as of Q1 2017 after selling out during the quarter.
  • Raymond James & Associates sold 37,879 Team Health Holdings Inc shares in Q1 2017, an estimated $1.65M.
  • Raymond James & Associates first reported a position in Team Health Holdings Inc in Q2 2013 and held it in 15 quarters.
  • Raymond James & Associates's Team Health Holdings Inc position peaked at $5.02M in Q1 2016.
  • 9 funds tracked by Wall St. Rank held Team Health Holdings Inc as of Q1 2017.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.